Using disease-modifying therapies in MS tends to reduce the risk of stroke, though effects vary depending on the type of DMT, ...

WhisperClaims has launched its 2025 R&D Confidence Monitor, revealing that while confidence is returning to the sector, significant disparities remain ...

The researchers examined 43 healthy men aged between 50 and 72, testing their epigenetic levels before and after implementing ...

Explore wasteful spending statistics revealing how Americans overspend, like frequent DoorDash orders and impulse buys, ...

The Survey found that security is the dominant factor in vendor selection decisions. This focus on security comes at a ...

Despite all these good vibes, course operators are reluctant. The NGF reports only 8 percent are interested in adding caddie ...

The Department of Justice said it’s pulling back from policing changes. Will cities and states have the tools to enforce them ...

According to scientists, that slow-motion drift will one day result in the total closure of the Pacific Basin and the birth ...

Real estate ETFs can help investors unlock higher income potential along with exposure to a diverse array of property types.

Results of the MIROCALS (Modifying Immune Responses and Outcomes in ALS) clinical trial are published in The Lancet. This is the first study to investigate the effectiveness and safety of low-dose ...

BridgeBio Pharma, Inc. announced that it will present research findings related to its drug acoramidis for treating variant transthyretin amyloid cardiomyopathy (ATTR-CM) at the upcoming Annual ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...